A pilot study: Subclinical hypothyroidism and free thyroid hormone measurement by immunoassay and mass spectrometry

Clinica Chimica Acta

Volumn 430, Issue , 2014, Pages 121-124

  Gounden, Verena ^a   Jonklaas, Jacqueline ^b   Soldin, Steven J ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Free thyroid hormone; Mass spectrometry; Subclinical hypothyroidism

Indexed keywords

LIOTHYRONINE; THYROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; OUTPATIENT; PILOT STUDY; PRIORITY JOURNAL; REFERENCE VALUE; SUBCLINICAL HYPOTHYROIDISM; THYROID HORMONE BLOOD LEVEL; ADOLESCENT; BLOOD; CHILD; CLASSIFICATION; HYPOTHYROIDISM; MIDDLE AGED; PRESCHOOL CHILD; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; HYPOTHYROIDISM; IMMUNOASSAY; MALE; MIDDLE AGED; PILOT PROJECTS; TANDEM MASS SPECTROMETRY; THYROID HORMONES; YOUNG ADULT;

EID: 84893187778     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.12.034     Document Type: Article

References (21)

1. Gharib H., Michael Tuttle R., Baskin H.J., Fish L.H., Singer P.A., McDermott M.T. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005, 90:581-585.
2. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160:526-534.
3. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87:489-499.
4. Baloch Z., Carayon P., Conte-Devolx B., et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3-126.
5. Midgley J.E., Christofides N.D. Point: legitimate and illegitimate tests of free-analyte assay function. Clin Chem 2009, 55:439-441.
6. Wilcox R.B., Nelson J.C. Counterpoint: legitimate and illegitimate tests of free-analyte assay function: we need to identify the factors that influence free-analyte assay results. Clin Chem 2009, 55:442-444.
7. Toldy E., Locsei Z., Szabolcs I., Bezzegh A., Kovacs G.L. Protein interference in thyroid assays: an in vitro study with in vivo consequences. Clin Chim Acta 2005, 352:93-104.
8. Van Deventer H.E., Mendu D.R., Remaley A.T., Soldin S.J. Inverse log-linear relationship between thyroid-stimulating hormone and free thyroxine measured by direct analog immunoassay and tandem mass spectrometry. Clin Chem 2011, 57:122-127.
9. Van Deventer H.E., Soldin S.J. The expanding role of tandem mass spectrometry in optimizing diagnosis and treatment of thyroid disease. Adv Clin Chem 2013, 61:127-152.
10. Soldin S.J., Soukhova N., Janicic N., Jonklaas J., Soldin O.P. The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta 2005, 358:113-118.
11. Soldin S.J., Cheng L.L., Lam Y., Werner A., Le A.D., Soldin O.P. Comparison of FT4 with log TSH on the Abbott Architect ci8200: pediatric reference intervals for free thyroxine and thyroid-stimulating hormone. Clin Chim Acta 2010, 411:250-252.
12. Tractenberg R.E., Jonklaas J., Soldin S.J. Agreement of immunoassay and tandem mass spectrometry in the analysis of cortisol and free t4: interpretation and implications for clinicians. Int J Anal Chem 2010, 2010. [Article ID 234808, 7 pages].
13. Surks M.I., Sievert R. Drugs and thyroid function. N Engl J Med 1995, 333:1688-1694.
14. Surks M.I., DeFesi C.R. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine: a paradox resolved. JAMA 1996, 275:1495-1498.
15. Harjai K.J., Licata A.A. Effects of amiodarone on thyroid function. Ann Intern Med 1997, 126:63-73.
16. Lazarus J.H. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998, 8:909-913.
17. Gu J., Soldin O.P., Soldin S.J. Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin Biochem 2007, 40:1386-1391.
18. Wu A.H.B., French D. Implementation of liquid chromatography/mass spectrometry into the clinical laboratory. Clin Chim Acta 2013, 420:4-10.
19. Soldin O.P., Jang M., Guo T., Soldin S.J. Pediatric reference intervals for free thyroxine and free triiodothyronine. Thyroid 2009, 19:669-702.
20. Siemens Dimension Vista Package insert FT4 September 2009, Siemens Healthcare Diagnostics (Tarrytown, NY).
21. Lepoutre T., Daumerie C., Gruson D. Measurement of TSH, FT4 and FT3 with immunoassays based on LOCI technology. Endocr Abstr 2012, 29:1675.